Depomed To Report Third Quarter Fiscal Year 2014 Financial Results On Wednesday, November 5, 2014

NEWARK, Calif., Oct. 27, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release third quarter fiscal year 2014 financial results after the market closes on Wednesday, November 5, 2014. The Company will host a conference call beginning at 4:30 pm EST, 1:30 pm PST to discuss its results.

Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on the investor relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed

Depomed is a specialty pharmaceutical company that commercializes products for pain and neurology related disorders.  Gralise^® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA^® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor^® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults.  Lazanda^® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform^® drug delivery technology.   Additional information about Depomed may be found at www.depomed.com.

CONTACT:
August J. Moretti  
Depomed, Inc.
510.744.8000
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/depomed-to-report-third-quarter-fiscal-year-2014-financial-results-on-wednesday-november-5-2014-906978311.html

SOURCE Depomed, Inc.

Related Links

http://www.depomed.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED